Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccine for prevention of cognitive decline and dementia in older adults at increased Alzheimer's disease risk
MOH_2022-12-25_012253Phase 2Not yet recruiting
- Sponsor
- פרופ תמיר בן-חור
- Start
- Dec 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bcg vaccine in Dementia and Alzheimer's disease (AD), sponsored by פרופ תמיר בן-חור. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
bcg vaccine
03
Conditions
DementiaAlzheimer's disease (AD)
Beyond the preview
Go deeper on MOH_2022-12-25_012253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-12-25_012253.